Ameriprise’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-414,384
| Closed | -$13.3M | – | 4038 |
|
|
2022
Q1 | $13.3M | Buy |
414,384
+1,064
| +0.3% | +$28.8K | ﹤0.01% | 1664 |
|
|
2021
Q4 | $10.9M | Buy |
413,320
+167,645
| +68% | +$4.26M | ﹤0.01% | 1919 |
|
|
2021
Q3 | $5.66M | Buy |
245,675
+68,934
| +39% | +$1.64M | ﹤0.01% | 2308 |
|
|
2021
Q2 | $4.65M | Sell |
176,741
-13,296
| -7% | -$334K | ﹤0.01% | 2503 |
|
|
2021
Q1 | $4.24M | Buy |
190,037
+23,367
| +14% | +$536K | ﹤0.01% | 2491 |
|
|
2020
Q4 | $3.27M | Sell |
166,670
-1,374
| -0.8% | -$22.8K | ﹤0.01% | 2543 |
|
|
2020
Q3 | $2.36M | Sell |
168,044
-43,410
| -21% | -$627K | ﹤0.01% | 2578 |
|
|
2020
Q2 | $2.4M | Buy |
211,454
+2,743
| +1% | +$25.1K | ﹤0.01% | 2511 |
|
|
2020
Q1 | $1.31M | Sell |
208,711
-410,352
| -66% | -$6.62M | ﹤0.01% | 2693 |
|
|
2019
Q4 | $12.6M | Buy |
619,063
+22,300
| +4% | +$417K | 0.01% | 1565 |
|
|
2019
Q3 | $9.92M | Sell |
596,763
-92,397
| -13% | -$1.6M | ﹤0.01% | 1692 |
|
|
2019
Q2 | $11.3M | Sell |
689,160
-100,354
| -13% | -$1.94M | 0.01% | 1623 |
|
|
2019
Q1 | $13.9M | Buy |
789,514
+166,670
| +27% | +$3.55M | 0.01% | 1423 |
|
|
2018
Q4 | $15.5M | Sell |
622,844
-152,672
| -20% | -$5.08M | 0.01% | 1231 |
|
|
2018
Q3 | $24.9M | Buy |
775,516
+34,335
| +5% | +$1.17M | 0.01% | 1130 |
|
|
2018
Q2 | $26.1M | Buy |
741,181
+37,977
| +5% | +$1.4M | 0.01% | 1015 |
|
|
2018
Q1 | $27.9M | Buy |
703,204
+210,551
| +43% | +$8.17M | 0.01% | 949 |
|
|
2017
Q4 | $18M | Sell |
492,653
-48,511
| -9% | -$1.84M | 0.01% | 1143 |
|
|
2017
Q3 | $22.1M | Buy |
541,164
+167,729
| +45% | +$6.5M | 0.01% | 982 |
|
|
2017
Q2 | $14.9M | Buy |
373,435
+8,095
| +2% | +$271K | 0.01% | 1244 |
|
|
2017
Q1 | $10.6M | Buy |
365,340
+90,697
| +33% | +$2.39M | 0.01% | 1476 |
|
|
2016
Q4 | $6.25M | Buy |
274,643
+97,269
| +55% | +$2.29M | ﹤0.01% | 1857 |
|
|
2016
Q3 | $4.69M | Buy |
177,374
+26,125
| +17% | +$527K | ﹤0.01% | 2048 |
|
|
2016
Q2 | $1.75M | Buy |
151,249
+5,920
| +4% | +$69.3K | ﹤0.01% | 2593 |
|
|
2016
Q1 | $1.47M | Buy |
145,329
+1,722
| +1% | +$19.3K | ﹤0.01% | 2675 |
|
|
2015
Q4 | $1.85M | Sell |
143,607
-2,865
| -2% | -$34.9K | ﹤0.01% | 2645 |
|
|
2015
Q3 | $1.63M | Sell |
146,472
-21,807
| -13% | -$266K | ﹤0.01% | 2728 |
|
|
2015
Q2 | $2.02M | Sell |
168,279
-1,387,466
| -89% | -$23M | ﹤0.01% | 2755 |
|
|
2015
Q1 | $30.6M | Sell |
1,555,745
-139,808
| -8% | -$2.92M | 0.02% | 753 |
|
|
2014
Q4 | $33.7M | Sell |
1,695,553
-130,505
| -7% | -$2.13M | 0.02% | 687 |
|
|
2014
Q3 | $29.3M | Buy |
1,826,058
+37,459
| +2% | +$635K | 0.02% | 744 |
|
|
2014
Q2 | $31.4M | Buy |
1,788,599
+60,601
| +4% | +$1.04M | 0.02% | 756 |
|
|
2014
Q1 | $29.6M | Buy |
1,727,998
+2,760
| +0.2% | +$42.5K | 0.02% | 779 |
|
|
2013
Q4 | $26.5M | Buy |
1,725,238
+689,263
| +67% | +$9.78M | 0.02% | 839 |
|
|
2013
Q3 | $19.2M | Buy |
1,035,975
+126,132
| +14% | +$2.28M | 0.01% | 1021 |
|
|
2013
Q2 | $15.8M | Buy |
+909,843
| New | +$12.5M | 0.01% | 1128 |
|
Other funds holding TVTY
BCMLT
PP
IA
Ameriprise's TVTY Position: Q2 2022 in Review
Ameriprise sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 414,384 shares — an estimated $13.3M sold.
Ameriprise first reported a position in TVTY in Q2 2013 and held it in 36 quarters. The position peaked at $33.7M in Q4 2014. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Ameriprise reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Ameriprise sold 414,384 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $13.3M.
- Ameriprise first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- Ameriprise's Tivity Health, Inc. Common Stock position peaked at $33.7M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.